Page last updated: 2024-08-26

artenimol and Mouth Neoplasms

artenimol has been researched along with Mouth Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (40.00)24.3611
2020's3 (60.00)2.80

Authors

AuthorsStudies
Deng, Y; Wu, R; Zhang, Q; Zheng, S1
Bao, B; Cheng, B; Hu, R; Ji, Y; Li, X; Liao, G; Luo, H; Ouyang, H; Shi, S; Wang, L; Wang, X; Wang, Y; Wang, Z; Xia, J; Xu, B1
Chaudhary, N; Dalal, SN; Kalwar, A; Kannan, S; Nair, S; Patil, R; Pawar, SN; Pawar, SS; Sharma, D; Sulkshane, P; Teni, T; Waghole, R; Yasser, M1
Lin, JN; Liu, ZZ; Zhao, YX; Zhou, GP1
Efferth, T; Erich, SA; Fleckenstein, L; Grinwis, GC; London, CA; Mol, JA; Rutteman, GR; Spee, B1

Other Studies

5 other study(ies) available for artenimol and Mouth Neoplasms

ArticleYear
Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
    Bioengineered, 2022, Volume: 13, Issue:1

    Topics: Artemisinins; Biomarkers, Tumor; Calcium Channels; Calcium-Binding Proteins; Cation Transport Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Progression; Down-Regulation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Potential, Mitochondrial; Mitochondrial Membrane Transport Proteins; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck

2022
Repurposing Dihydroartemisinin to Combat Oral Squamous Cell Carcinoma, Associated with Mitochondrial Dysfunction and Oxidative Stress.
    Oxidative medicine and cellular longevity, 2023, Volume: 2023

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cisplatin; Head and Neck Neoplasms; Humans; Mice; Mitochondria; Mouth Neoplasms; Oxidative Stress; Reactive Oxygen Species; Squamous Cell Carcinoma of Head and Neck

2023
Elevated translationally controlled tumour protein promotes oral cancer progression and poor outcome.
    Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2023, Volume: 52, Issue:9

    Topics: Artemisinins; Biomarkers, Tumor; Humans; Mouth Neoplasms; Myeloid Cell Leukemia Sequence 1 Protein; Tumor Protein, Translationally-Controlled 1

2023
[Effect of dihydroartemisinin on multidrug resistance of human oral squamous cell carcinoma cell line KBV200 by regulating ROS-MAPK pathway].
    Shanghai kou qiang yi xue = Shanghai journal of stomatology, 2019, Volume: 28, Issue:6

    Topics: Artemisinins; Carcinoma, Squamous Cell; Drug Resistance, Multiple; Humans; Mouth Neoplasms; Reactive Oxygen Species

2019
Safety and efficacy field study of artesunate for dogs with non-resectable tumours.
    Anticancer research, 2013, Volume: 33, Issue:5

    Topics: Animals; Antimalarials; Artemisinins; Artesunate; Carcinoma, Squamous Cell; Cell Proliferation; Dog Diseases; Dogs; Lymphoma; Mouth Neoplasms; Treatment Outcome; Tumor Cells, Cultured

2013